Back to Journals » ImmunoTargets and Therapy » Journal Metrics

ImmunoTargets and Therapy

ISSN: 2253-1556


Usage:

  • 40,125 Annual downloads/views

Speed/ acceptance:

  • 53 days average from submission to first editorial decision
  • 17 days average from editorial acceptance to publication
  • 35% acceptance rate

Citation metrics:

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

  • 6.2 (Q1) (2023) Impact Factor *
  • 8.1 (2023) 5 year Impact Factor
  • 16.5 (Q1) (2023) CiteScore
  • 1.772 (2023) Source Normalized Impact per Paper (SNIP)
  • 2.140 (2023) Scimago Journal & Country Rank (SJR)
  • PubMed and PubMed Central (Immunotargets Ther)
  • Scopus, from 2022
  • Embase, from 2015
  • Directory of Open Access Journals (DOAJ)
  • The Open Access Initiative (OAIster)
*
  • Emerging Sources Citation Index (ESCI)

 

For more details, please read our journal metrics summary.